Filing search / Pulmatrix, Inc. / "Litigation" / Page 5

8-K

EX-99.1

g4dbeftmmwf 5woh5

1 Nov 19

Pulmatrix Reports Q3 2019 Results

9:05am

8-K

EX-99.1

79aidb3w l9iddutzs

5 Aug 19

Pulmatrix Reports Q2 2019 Results

9:05am

8-K

EX-99.1

tayv8n1grmsu

16 May 19

Pulmatrix Announces Leadership Change

9:15am

8-K

EX-99.1

l4yejtp6gs

15 May 19

Pulmatrix Reports Q1 2019 Results

9:06am

8-K

EX-99.1

dnsunzxppyle9

15 Apr 19

Pulmatrix and Cipla Technologies LLC enter into Definitive Agreement for the Development and Commercialization of PulmazoleTM

5:00pm

8-K

EX-99.1

cl78e wi23

9 Apr 19

Pulmatrix, Inc. Announces Closing of $16.6 Million Upsized Public Offering

4:05pm

424B4

6clqahlgteeh1bk6pd

5 Apr 19

Prospectus supplement with pricing info

4:31pm

8-K

EX-99.1

cvbvs dgqi

4 Apr 19

Pulmatrix, Inc. Announces Pricing of $14.4 Million Upsized Public Offering

4:43pm

8-K

EX-99.1

phpg2v5xfu80r96dk

1 Apr 19

Entry into a Material Definitive Agreement

4:16pm

8-K

EX-99.1

32npnlfyt5lns

19 Feb 19

Pulmatrix Reports 2018 Financial Results; Provides 2019 Outlook on Pulmonary Disease Pipeline

9:05am